HPV18 ‐Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights
Journal of Obstetrics and Gynaecology Research · 2026
DOI: 10.1111/jog.70426 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Obstetrics and Gynaecology Research, 2026. Verfasst von Jumpei Ogura und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Saiseikai Noe Hospital, Osaka, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Large Cell, Carcinoma, Neuroendocrine, Human papillomavirus 18. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
HPV18‐positive cervical large cell neuroendocrine carcinoma (LCNEC) is exceptionally rare. We report a 40‐years‐old woman with FIGO 2018 stage IVB LCNEC who progressed rapidly despite paclitaxel–carboplatin–bevacizumab plus pembrolizumab, followed by concurrent chemoradiotherapy and later cytotoxic regimens. Biopsy showed chromogranin A and synaptophysin positivity, diffuse p16, and Ki‐67%~80%. Comprehensive profiling revealed very low tumor mutational burden (TMB, 1.21/Mb), microsatellite stability, no homologous recombination deficiency, and minimal PD‐L1 (~1%), consistent with a poorly immunogenic tumor microenvironment (TME). This profile may explain the limited effect of immune checkpoint inhibition in this histology. The case suggests that HPV or p16 positivity alone did not predict clinical benefit from pembrolizumab‐based therapy in advanced cervical LCNEC, and supports careful biological assessment before treatment selection. These observations provide practical guidance for clinicians and support evaluation of alternative or investigational strategies for this aggressive tumor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Saiseikai Noe Hospital, Osaka, Japan.
ORCID-Profile: Jumpei Ogura, Takuya Yokoe
Zitieren
APA
Ogura, J., Sato, S., Koshida, Y., Kasuga, M., Yokoe, T., & Kanamoto, N. (2026). HPV18 ‐Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights. Journal of Obstetrics and Gynaecology Research. https://doi.org/10.1111/jog.70426
Vancouver
Ogura J, Sato S, Koshida Y, Kasuga M, Yokoe T, Kanamoto N. HPV18 ‐Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights. Journal of Obstetrics and Gynaecology Research. 2026. doi:10.1111/jog.70426
BibTeX
@article{Ogura2026,
author = {Ogura, Jumpei and Sato, Shimpei and Koshida, Yuichiro and Kasuga, Maya and Yokoe, Takuya and Kanamoto, Naokazu},
title = {HPV18 ‐Positive Cervical Large Cell Neuroendocrine Carcinoma With Rapid Progression Despite Pembrolizumab Combined With Chemotherapy: A Case Report With Immunogenomic Insights},
journal = {Journal of Obstetrics and Gynaecology Research},
year = {2026},
doi = {10.1111/jog.70426}
}
EUVIMED